4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-21-012172
Options or other derivatives
- Chief Executive Officer acquired 435,072 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Erlander Mark Chief Executive Officer | 2021-06-10 | Grant or award · Stock Options | +435,072 | 815,272 | D | ||
Loading xslF345X03/wf-form4_162370149350115.xml…